Journal of Sulfur Chemistry
5
C20H14Cl2N2OS (401.31): C 59.86%, H 3.52%, N 6.98%, S 7.99%. Found: C 59.64%, H 3.48%,
N 6.92%, S 7.83%.
3.1.2. 4-Methyl-Nꢀ-(4-methylphenylcarbonothioyl)-N-phenylbenzohydrazide (3b)
Yellow crystal, m.p: 153 C. IR (KBr) (νmax/cm–1): 3470, 3293, 3245, 1668, 1593, 1489, 1265,
1073, 748. 1H NMR (400.1 MHz, CDCl3): δ = 2.32 (3 H, s, Me), 2.36 (3 H, s, Me), 7.04 (2 H,
d, 3JHH = 8.0 Hz, 2 CH), 7.11 (2 H, d, 3JHH = 8.0 Hz, 2 CH), 7.20–7.28 (3 H, m, 3 CH), 7.33
(2 H, d, 3JHH = 8.0 Hz, 2 CH), 7.48 (2 H, d, 3JHH = 8.0 Hz, 2 CH), 7.68 (2 H, d, 3JHH = 8.0
Hz, 2 CH), 10.29 (1 H, s, NH). 13C NMR (100.6 MHz, CDCl3): δ = 21.4 (Me), 21.5 (Me), 125.1
(2 CH), 127.0 (CH), 127.3 (2 CH), 128.7 (2 CH), 128.9 (2 CH), 129.1 (2 CH), 129.2 (CH), 131.0
+
=
=
(C), 135.9 (C), 141.7 (C), 142.3 (C), 169.7 (C O), 199.3 (C S). MS m/z 360 (M , 10). Anal.
Calcd for C22H20N2OS (360.47): C 73.30%, H 5.59%, N 7.77%, S 8.90%. Found: C 73.42%,
H 5.64%, N 7.80%, S 8.94%.
3.1.3. N-phenyl-Nꢀ-(phenylcarbonothioyl)-benzohydrazide (3c)
Yellow crystal, m.p: 157C. IR (KBr) (νmax/cm–1): 3468, 3290, 3253, 1659, 1514, 1413, 1253,
870. 1H NMR (400.1 MHz, CDCl3): δ = 7.21–7.29 (5 H, m, 5 CH), 7.32–7.40 (5 H, m, 5 CH),
7.47 (1 H, t, 3JHH = 7.2 Hz, CH), 7.62 (2 H, d, 3JHH = 6.8 Hz, 2 CH), 7.75 (2 H, d, 3JHH = 7.2
Hz, 2 CH), 10.19 (1 H, s, NH). 13C NMR (100.6 MHz, CDCl3): δ = 125.1 (CH), 127.2 (CH),
127.2 (2 CH), 128.0 (2 CH), 128.5 (2 CH), 128.9 (CH), 129.0 (2 CH), 131.1 (2+CH), 131.7
=
=
(2 CH), 134.0 (C), 134.1 (C), 138.9 (C), 169.6 (C O), 199.7 (C S). MS m/z 332 (M , 20). Anal.
Calcd for C20H16N2OS (332.40): C 72.26%, H 4.85%, N 8.43%, S 9.65%. Found: C 72.33%,
H 4.79%, N 8.38%, S 9.70%.
Disclosure statement
No potential conflict of interest was reported by the authors.
Supplemental material
CCDC 1047625 contains the supplementary crystallographic data for this paper. These data can be obtained free of
References
[1] Nielsen TE, Schreiber SL. Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed.
2008;47:48–56.
[2] Poli G, Giambastiani G. An epiisopicropodophyllin aza analogue via palladium-catalyzed pseudo-domino cycliza-
tion. J Org Chem. 2002;67:9456–9459.
[3] Fogg DE, dos Santos EN. Tandem catalysis: a taxonomy and illustrative review. Coord Chem Rev. 2004;248:
2365–2379.
[4] Tietze LF. Domino reactions in organic synthesis. Chem Rev. 1996;96:115–136.
[5] Weber L. The application of multi-component reactions in drug discovery. Curr Med Chem. 2002;9:1241–1253.
[6] DÖmling A. Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem Rev.
2006;106:17–89.
[7] Ugi I, Werner B, DÖmling A. The chemistry of isocyanides, their multicomponent reactions and their libraries.
Molecules. 2003;8:53–66.
[8] Orru RVA, de Greef M. Recent advances in solution-phase multicomponent methodology for the synthesis of
heterocyclic compounds. Synthesis. 2003;10:1471–1499.
[9] Bienayme H, Hulme C, Oddon G, Schmitt P. Maximizing synthetic efficiency: multi-component transformations
lead the way. Chem Eur J. 2000;6:3321–3329.